Table 2b –
IDC (All BB) |
NF (Control) | F vs. NF | R | NR | R vs. NR | |
---|---|---|---|---|---|---|
Clinical characteristic | 47 | 4 | p | 31 (66.0%) | 16 (34.0%) | p |
LVEF, % | 26.2±8.9 | 58.8±7.4 | 0.001 | 25.6±8.2 | 27.3±10.5 | 0.68 |
RVEF, % | 27.1±8.9 | 38.3±4.7 | 0.03 | 27.0±8.7 | 27.2±9.7 | 0.95 |
LV end diastolic vol., ml | 229±92 | - | - | 220±83 | 247±110 | 0.50 |
Heart rate, bpm | 84.5±20.3 | 74.0±18.2 | 0.64 | 86.7±21.3 | 80.3±17.3 | 0.24 |
QRS, ms | 115±31 | 101±9 | 0.51 | 107±24 | 133±39 | 0.03 |
Norepinephrine, pg/ml | 489±327 | 372±152 | 0.69 | 450±261 | 574±438 | 0.74 |
Systolic blood press., mm Hg | 107±14 | 118±29 | 0.56 | 106±13 | 109±17 | 0.46 |
Mean PA pressure, mm Hg | 24.1±10.5 | 20.0±3.0 | 0.59 | 22.6±9.8 | 27.1±11.5 | 0.18 |
Cardiac index, L/min/m2 | 2.2±0.6 | 3.0±0.5 | 0.05 | 2.3±0.7 | 2.2±0.6 | 0.91 |
IDC=Idiopathic dilated cardiomyopathy; BB=β-blocker; F=Failing; NF=Nonfailing; R=Responder; NR=Nonresponder; PA=Pulmonary artery